Syndivia signs distribution agreement with Sigma-Aldrich

Syndivia has signed a distribution agreement with Sigma-Aldrich. Following this agreement, Syndivia’s proprietary bioconjugation reagents are now available in the catalog of Sigma-Aldrich. For the complete list of products visit:

“It is our priority to provide the research community with the cutting-edge tools for bioconjugation. Commercialization of APN reagents is an important step for advancing therapeutic and diagnostic applications of bioconjugates” – commented Oleksandr Koniev, Syndivia’s CEO.